Related Experiment Videos
[Correction of fatal genetic diseases using bone marrow transplantation. 2]
1Abteilung für Hämatologie, Onkologie und Immunologie, Universitäts-Kinderklinik Jussuf Ibrahim, Jena.
Insights
Allogeneic bone marrow transplants successfully treated four children with severe genetic disorders, including aplastic anemia and Gaucher
Area of Science:
- Hematology
- Immunology
- Genetics
Background:
- Congenital hematopoietic and lymphoid stem cell disorders present significant challenges.
- Allogeneic bone marrow transplantation is a potential therapeutic strategy for these conditions.
Observation:
- Four pediatric patients with distinct congenital disorders underwent bone marrow transplantation.
- The patients had Blackfan-Diamond anemia, Gaucher's disease, Kostmann agranulocytosis, and chronic granulomatous disease.
Findings:
- A preparatory regimen of busulfan, cyclophosphamide, and total nodal irradiation was administered.
- Successful hematopoietic ablation and donor stem cell engraftment were achieved in all patients.
- The underlying genetic disorders were completely corrected post-transplantation.
Implications:
- Allogeneic bone marrow transplantation is a viable curative treatment for specific congenital stem cell disorders.
- This approach offers a promising therapeutic avenue for children with life-threatening genetic diseases.
- Long-term survival and complete correction of disease manifestations were observed in all treated children.
Abstract:
Genetic diseases can be treated by transplantation of normal allogeneic bone marrow. Four patients with congenital disorders of their hematopoietic and/or lymphoid stem cells have been transplanted. One patient had a congenital aplastic anemia (Blackfan-Diamond), one had Gaucher's disease, one had congenital agranulocytosis Kostmann and one had chronic granulomatous disease. All patients received busulfan, cyclophosphamide and total nodal irradiation as preparatory regimen. Total nodal irradiation and cyclophosphamide were used as immunosuppressive agents. In all cases hematopoietic ablation and donor lymphoid and hematopoietic engraftment were achieved. The basic disorders of all transplanted children could be corrected completely. All children are alive and well.